Sign In
Buy ZBH
$93.93
-1.03 (-1.08%)
At Close: Jul 31, 2026
Zimmer Biomet (ZBH) Q1 Earnings Top Estimates, FY22 View Up
12:02pm, Tuesday, 03'rd May 2022
Each of Zimmer Biomet's (ZBH) geographic segments and product divisions recorded year-over-year sales growth at CER.
Zimmer Biomet (ZBH) Q1 Earnings and Revenues Surpass Estimates
11:45am, Tuesday, 03'rd May 2022 Zacks Investment Research
Zimmer (ZBH) delivered earnings and revenue surprises of 15% and 4.10%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Zimmer Biomet (ZBH) Q1 Earnings and Revenues Surpass Estimates
09:02am, Tuesday, 03'rd May 2022
Zimmer (ZBH) delivered earnings and revenue surprises of 15% and 4.10%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Is a Surprise Coming for Zimmer Biomet (ZBH) This Earnings Season?
04:03pm, Monday, 02'nd May 2022 Zacks Investment Research
Zimmer Biomet (ZBH) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Is a Surprise Coming for Zimmer Biomet (ZBH) This Earnings Season?
01:33pm, Monday, 02'nd May 2022
Zimmer Biomet (ZBH) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
DENTSPLY SIRONA (XRAY) to Post Q1 Earnings: What's in Store?
12:25pm, Monday, 02'nd May 2022 Zacks Investment Research
DENTSPLY SIRONA's (XRAY) first-quarter results are likely to reflect strong performance at Technologies & Equipment business.
McKesson (MCK) to Report Q4 Earnings: What's in the Cards?
12:21pm, Monday, 02'nd May 2022 Zacks Investment Research
McKesson's (MCK) fiscal fourth-quarter results are likely to reflect the solid show by the U.S. Pharmaceutical and Specialty Solutions segment.
Zimmer Biomet (ZBH) Expected to Beat Earnings Estimates: Should You Buy?
07:01pm, Tuesday, 26'th Apr 2022 Zacks Investment Research
Zimmer (ZBH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
PerkinElmer (PKI) to Post Q1 Earnings: What's in the Cards?
12:40pm, Tuesday, 26'th Apr 2022 Zacks Investment Research
PerkinElmer's (PKI) first-quarter results are likely to reflect strong performance at the Diagnostics segment.
AmerisourceBergen (ABC) to Post Q2 Earnings: What's in Store?
12:39pm, Tuesday, 26'th Apr 2022 Zacks Investment Research
AmerisourceBergen's (ABC) fiscal second-quarter results are likely to reflect solid performance at the U.S. Healthcare Solutions segment.
Zimmer Biomet (ZBH) to Report Q1 Earnings: What's in Store?
11:17am, Tuesday, 26'th Apr 2022
Zimmer Biomet (ZBH) might have struggled to maintain the recovery trend in the first half of Q1 with severe-than-expected staffing shortages and supply issues leading to procedural deferrals.
What's in Store for West Pharmaceutical's (WST) Q1 Earnings?
01:47pm, Monday, 25'th Apr 2022 Zacks Investment Research
West Pharmaceutical's (WST) first-quarter results are likely to reflect strength in the Proprietary Products business.
DexCom (DXCM) to Report Q1 Earnings: What's in the Cards?
01:46pm, Monday, 25'th Apr 2022 Zacks Investment Research
DexCom's (DXCM) first-quarter results are likely to reflect rising global awareness of its real-time CGM.
3 Medical Product Stocks Poised to Beat This Earnings Season
11:54am, Monday, 25'th Apr 2022 Zacks Investment Research
Medical product companies' results are likely to reflect base business recovery on a year-over-year basis. Let's see how ALC, ZBH and CSII are poised ahead of their earnings releases.
3 Medical Product Stocks Poised to Beat This Earnings Season
09:02am, Monday, 25'th Apr 2022
Medical product companies' results are likely to reflect base business recovery on a year-over-year basis. Let's see how ALC, ZBH and CSII are poised ahead of their earnings releases.
